Agreements
BioTransplant (Charlestown, Massachusetts) said it has agreed with Gambro BCT (Lakewood, Colorado) to terminate the companies distribution agreement for the Eligix HDM Cell Separation Systems. Eligix systems use monoclonal antibodies to remove unwanted cells from bone marrow, peripheral blood stem cell and donor leukocyte grafts used in transplant procedures. The termination was mutually agreed upon by both parties to settle all claims and disputes between the companies. As part of the termination agreement, BioTransplant will pay Gambro an undisclosed amount to repurchase unused inventory, and Gambro will agree to provide customer support through Jan. 15, 2003.
CADx Systems (Beavercreek, Ohio) has signed a development and distribution agreement with GE …
No comments:
Post a Comment